Related Experiment Videos
IgA in Sjögren's syndrome
Y Levy1, M Dueymes, Y L Pennec
1Laboratory of Immunology, Brest University Medical School Hospital, France.
Clinical and Experimental Rheumatology
|September 1, 1994
Summary
Immunoglobulin A (IgA) may play a key role in Sjögren's syndrome (SS) pathogenesis by linking B cell activation and T cell dysfunction. Further research is needed to confirm IgA's role in SS disease activity.
Area of Science:
- Immunology
- Rheumatology
Background:
- Sjögren's syndrome (SS) involves B cell activation, leading to hypergammaglobulinemia, immune complexes, and autoantibodies.
- Activated T cells are prevalent in exocrine gland infiltrates, indicating cellular immune involvement in SS.
Purpose of the Study:
- To explore the potential role of Immunoglobulin A (IgA) in the pathogenesis of Sjögren's syndrome (SS).
- To investigate the link between IgA abnormalities and SS disease activity.
Main Methods:
- Review of existing studies on immunological abnormalities in SS patients.
- Analysis of reported levels of serum and secretory IgA, IgA-rheumatoid factor, and IgA-containing immune complexes.
Main Results:
- High levels of IgA, IgA-rheumatoid factor, and IgA-containing CIC are frequently reported in SS.
- Recent findings suggest a correlation between disease activity and elevated IgA-containing CIC.
- IgA is the immunoglobulin class most reliant on T cell help, suggesting a bridging role.
Conclusions:
- IgA may bridge the gap between activated B cells and defective T cells in SS pathogenesis.
- Longitudinal studies assessing total IgA and IgA autoantibodies are necessary to fully elucidate their role in SS.